Clinical Trial Update: Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas [Phase 2]

View source ↗

Summary

Phase 2 trial update for Abraxane in CIMP-High colorectal and small bowel adenocarcinomas; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastrointestinal Tract Cancer
• Small Intestine Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Cancer, Cancer of Gastrointestinal Tract | Phase 2 | Status: COMPLETED | Results posted: 2020-01-18